LivaNova (LIVN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $77.58, -1.17% vs the prior close of $78.50.
- Volume 773.98K shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
LIVN dips 1.2% to $77.58. Closed at $77.58, -1.17% vs the prior close of $78.50. Day range $77.18–$79.31, opened at $78.69.
LIVN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — LIVN dips 1.2% to $77.58
- Closed at $77.58, -1.17% vs the prior close of $78.50. Day range $77.18–$79.31, opened at $78.69.
- Volume was 773.98K shares, 1.2x its 50-day average of 635.84K.
- Price is -1.1% vs its 50-day average ($78.42) and +7.7% vs its 200-day average ($72.04).
- 52-week range $48.82–$85.76; today's close sits at 78% of that range, 9.5% below the 52-week high.
Oct 15, 2026 — LIVN jumps 3.2% to $78.50
- Closed at $78.50, +3.18% vs the prior close of $76.08. Day range $76.19–$79.11, opened at $76.90.
- Volume was 738.00K shares, 1.1x its 50-day average of 658.33K.
- Price is +0.1% vs its 50-day average ($78.39) and +9.1% vs its 200-day average ($71.96).
- 52-week range $48.82–$85.76; today's close sits at 80% of that range, 8.5% below the 52-week high.
Oct 14, 2026 — LIVN dips 0.4% to $76.08
- Closed at $76.08, -0.38% vs the prior close of $76.37. Day range $75.13–$77.28, opened at $75.82.
- Volume was 464.60K shares, 0.7x its 50-day average of 674.73K.
- Price is -2.9% vs its 50-day average ($78.38) and +5.8% vs its 200-day average ($71.88).
- 52-week range $48.82–$85.76; today's close sits at 74% of that range, 11.3% below the 52-week high.
Oct 13, 2026 — LIVN dips 1.2% to $76.37
- Closed at $76.37, -1.16% vs the prior close of $77.27. Day range $76.12–$78.10, opened at $77.34.
- Volume was 561.30K shares, 0.8x its 50-day average of 676.72K.
- Price is -2.8% vs its 50-day average ($78.57) and +6.3% vs its 200-day average ($71.82).
- 52-week range $48.82–$85.76; today's close sits at 75% of that range, 10.9% below the 52-week high.
Oct 12, 2026 — LIVN rises 1.2% to $77.27
- Closed at $77.27, +1.15% vs the prior close of $76.39. Day range $75.99–$77.35, opened at $76.12.
- Volume was 1.03M shares, 1.5x its 50-day average of 666.42K.
- Price is -1.8% vs its 50-day average ($78.69) and +7.7% vs its 200-day average ($71.75).
- 52-week range $48.82–$85.76; today's close sits at 77% of that range, 9.9% below the 52-week high.
Oct 9, 2026 — LIVN rises 0.6% to $76.39
- Closed at $76.39, +0.63% vs the prior close of $75.91. Day range $75.62–$77.66, opened at $76.12.
- Volume was 339.40K shares, 0.5x its 50-day average of 672.55K — lighter than usual.
- Price is -3.0% vs its 50-day average ($78.75) and +6.6% vs its 200-day average ($71.68).
- 52-week range $48.82–$85.76; today's close sits at 75% of that range, 10.9% below the 52-week high.
Oct 8, 2026 — LIVN ends flat (-0.0%) to $75.91
- Closed at $75.91, -0.03% vs the prior close of $75.93. Day range $74.23–$76.25, opened at $75.45.
- Volume was 467.20K shares, 0.7x its 50-day average of 673.24K.
- Price is -3.7% vs its 50-day average ($78.84) and +6.0% vs its 200-day average ($71.61).
- 52-week range $48.82–$85.76; today's close sits at 73% of that range, 11.5% below the 52-week high.
Oct 7, 2026 — LIVN rises 1.3% to $75.93
- Closed at $75.93, +1.33% vs the prior close of $74.93. Day range $74.44–$76.26, opened at $75.06.
- Volume was 692.10K shares, 1.0x its 50-day average of 670.14K.
- Price is -3.8% vs its 50-day average ($78.95) and +6.1% vs its 200-day average ($71.55).
- 52-week range $48.82–$85.76; today's close sits at 73% of that range, 11.5% below the 52-week high.
Oct 6, 2026 — LIVN dips 2.0% to $74.93
- Closed at $74.93, -1.96% vs the prior close of $76.43. Day range $74.58–$76.80, opened at $76.80.
- Volume was 424.50K shares, 0.6x its 50-day average of 671.38K.
- Price is -5.2% vs its 50-day average ($79.07) and +4.8% vs its 200-day average ($71.48).
- 52-week range $48.82–$85.76; today's close sits at 71% of that range, 12.6% below the 52-week high.
Oct 5, 2026 — LIVN rises 1.8% to $76.43
- Closed at $76.43, +1.81% vs the prior close of $75.07. Day range $74.23–$76.90, opened at $75.56.
- Volume was 558.90K shares, 0.8x its 50-day average of 668.45K.
- Price is -3.5% vs its 50-day average ($79.19) and +7.0% vs its 200-day average ($71.42).
- 52-week range $48.82–$85.76; today's close sits at 75% of that range, 10.9% below the 52-week high.
Oct 2, 2026 — LIVN rises 0.5% to $75.07
- Closed at $75.07, +0.50% vs the prior close of $74.70. Day range $74.64–$76.76, opened at $75.68.
- Volume was 528.50K shares, 0.8x its 50-day average of 672.02K.
- Price is -5.2% vs its 50-day average ($79.22) and +5.2% vs its 200-day average ($71.35).
- 52-week range $48.82–$85.76; today's close sits at 71% of that range, 12.5% below the 52-week high.
LIVN latest news & SEC filings
Every SEC filing by or about LIVN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bianchi Francesco sold 3,500 shares at $78.01 (≈$273.04K) on Sep 10, 2026
- Bianchi Francesco sold 3,500 shares at $78.01 (≈$273.04K) on Sep 10, 2026
- Bianchi Francesco sold 3,500 shares at $78.01 (≈$273.04K) on Sep 10, 2026
- Bianchi Francesco sold 3,500 shares at $78.01 (≈$273.04K) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Story Brooke sold 2,300 shares at $81.42 (≈$187.27K) on Sep 4, 2026
- Story Brooke sold 2,300 shares at $81.42 (≈$187.27K) on Sep 4, 2026
- Story Brooke sold 2,300 shares at $81.42 (≈$187.27K) on Sep 4, 2026
- Story Brooke sold 2,300 shares at $81.42 (≈$187.27K) on Sep 4, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 4, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 2, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 6, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · Form IRANNOTICE — IRANNOTICE filing
IRANNOTICE filing
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $390.59M (prior year $352.52M) (+10.8% vs Jun 30, 2025)
- Net income: $108.57M (prior year $27.16M) (+299.7% vs Jun 30, 2025)
- Diluted EPS: $1.93 (prior year $0.50) (+286.0% vs Jun 30, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade LIVN
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 25, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.17% (largest 3.2%).
- Liquidity: about 648.45K shares (≈$50.31M) trade per day on average.
- 52-week position: $77.58 vs a range of $48.82–$85.76 (78% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Francesco Bianchi sold 3,500 shares on Sep 10, 2026.
- Latest filings: 10-Q Aug 5, 2026; 8-K Aug 5, 2026; 8-K Jun 11, 2026.
- Share count: 55.09M shares outstanding (Jul 29, 2026), +0.9% vs a year earlier.
- Listing: Nasdaq · industry: Electromedical & Electrotherapeutic Apparatus.
LIVN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 78.69 | 79.31 | 77.18 | 77.58 | 773.98K |
| Oct 15, 2026 | 76.90 | 79.11 | 76.19 | 78.50 | 738.00K |
| Oct 14, 2026 | 75.82 | 77.28 | 75.13 | 76.08 | 464.60K |
| Oct 13, 2026 | 77.34 | 78.10 | 76.12 | 76.37 | 561.30K |
| Oct 12, 2026 | 76.12 | 77.35 | 75.99 | 77.27 | 1.03M |
| Oct 9, 2026 | 76.12 | 77.66 | 75.62 | 76.39 | 339.40K |
| Oct 8, 2026 | 75.45 | 76.25 | 74.23 | 75.91 | 467.20K |
| Oct 7, 2026 | 75.06 | 76.26 | 74.44 | 75.93 | 692.10K |
| Oct 6, 2026 | 76.80 | 76.80 | 74.58 | 74.93 | 424.50K |
| Oct 5, 2026 | 75.56 | 76.90 | 74.23 | 76.43 | 558.90K |
| Oct 2, 2026 | 75.68 | 76.76 | 74.64 | 75.07 | 528.50K |
| Oct 1, 2026 | 76.44 | 77.15 | 74.47 | 74.70 | 767.20K |
| Sep 30, 2026 | 77.11 | 77.11 | 75.39 | 76.50 | 970.70K |
| Sep 29, 2026 | 76.71 | 77.15 | 76.13 | 76.99 | 567.80K |
| Sep 28, 2026 | 76.13 | 77.66 | 75.46 | 77.21 | 570.70K |
| Sep 25, 2026 | 75.44 | 77.46 | 75.12 | 76.63 | 745.30K |
| Sep 24, 2026 | 77.26 | 77.45 | 74.11 | 75.44 | 1.06M |
| Sep 23, 2026 | 78.39 | 79.02 | 76.70 | 77.16 | 493.10K |
| Sep 22, 2026 | 79.19 | 80.19 | 78.18 | 78.49 | 640.50K |
| Sep 21, 2026 | 78.39 | 78.63 | 76.83 | 78.17 | 579.20K |
About LivaNova
LivaNova (LIVN) is listed on the Nasdaq and classified by the SEC under “Electromedical & Electrotherapeutic Apparatus”. Its business address is in GLOUCESTER. State of incorporation: United Kingdom. Fiscal year ends December 31. SEC CIK 1639691.
LIVN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| James Christopher Barry | Director | Jun 17, 2026 |
| Francesco Bianchi | Director | Sep 14, 2026 |
| Seng Stacy Enxing | Director | Jun 17, 2026 |
| William A Kozy | Director | Jun 17, 2026 |
| Vladimir Makatsaria | Chief Executive Officer | Apr 1, 2026 |
| Jette Nygaard-Andersen | Director | Jun 17, 2026 |
| Susan M Podlogar | Director | Jun 17, 2026 |
| Todd C Schermerhorn | Director | Jun 17, 2026 |
| Brooke Story | Director | Sep 8, 2026 |
| Peter M Wilver | Director | Jun 17, 2026 |
| Donald Zurbay | Director | Jun 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Stephanie Bolton | President, Global Epilepsy | Apr 1, 2026 |
| Stefano Folli | President, Cardiopulmonary | Aug 5, 2026 |
| Michael Damon Hutchinson | SVP, CLO and Company Secretary | Dec 17, 2025 |
| Natalia Kozmina | Chief Human Resources Officer | Apr 1, 2026 |
| Anne M. Liddy | Chief Legal Officer | Sep 16, 2026 |
| Vladimir Makatsaria | Chief Executive Officer | Apr 1, 2026 |
| Franco Poletti | President, Cardiopulmonary | Apr 1, 2026 |
| Alex Shvartsburg | Chief Financial Officer | Apr 1, 2026 |
| Ahmet Tezel | Chief Innovation Officer | Aug 13, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 10, 2026 | Francesco Bianchi | Sale | 3,500 | $78.01 |
| Sep 10, 2026 | Francesco Bianchi | Sale | 3,500 | $78.01 |
| Sep 10, 2026 | Francesco Bianchi | Sale | 3,500 | $78.01 |
| Sep 10, 2026 | Francesco Bianchi | Sale | 3,500 | $78.01 |
| Sep 4, 2026 | Brooke Story | Sale | 2,300 | $81.42 |
| Sep 4, 2026 | Brooke Story | Sale | 2,300 | $81.42 |
| Sep 4, 2026 | Brooke Story | Sale | 2,300 | $81.42 |
| Sep 4, 2026 | Brooke Story | Sale | 2,300 | $81.42 |
| Aug 31, 2026 | Francesco Bianchi | Sale | 1,650 | $79.72 |
| Aug 31, 2026 | Francesco Bianchi | Sale | 1,650 | $79.72 |
| Aug 31, 2026 | Francesco Bianchi | Sale | 1,650 | $79.72 |
| Aug 31, 2026 | Francesco Bianchi | Sale | 1,650 | $79.72 |
| Aug 11, 2026 | Ahmet Tezel | Sale | 2,675 | $77.74 |
| Aug 11, 2026 | Ahmet Tezel | Sale | 2,675 | $77.74 |
| Aug 11, 2026 | Ahmet Tezel | Sale | 2,675 | $77.74 |
LIVN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.39B | $-242.47M | -4.45 | $254.34M |
| Dec 31, 2024 | $1.25B | $63.23M | 1.16 | $183.04M |
| Dec 31, 2023 | $1.15B | $17.55M | 0.32 | $74.91M |
| Dec 31, 2022 | $1.02B | $-86.25M | -1.61 | $69.92M |
| Dec 31, 2021 | $1.04B | $-135.82M | -2.68 | $102.54M |
Latest balance sheet: total assets $2.64B, total liabilities $1.32B, cash $516.62M (as of Jun 30, 2026).
LIVN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $78.14 |
| May 6, 2026 | 8-K Item 2.02 (results) | $66.26 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $70.29 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $50.81 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $47.36 |
| May 7, 2025 | 8-K Item 2.02 (results) | $43.50 |
| Feb 25, 2025 | 8-K Item 2.02 (results) | $41.70 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $51.34 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
| Feb 21, 2024 | 8-K Item 2.02 (results) | — |
| Nov 1, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Electromedical & Electrotherapeutic Apparatus
Medtronic (MDT)Integer (ITGR)TransMedics (TMDX)Axogen (AXGN)Nexalin Technology (NXL)Conmed (CNMD)Ceribell (CBLL)InMode (INMD)Electromed (ELMD)Hyperfine (HYPR)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on LIVN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.